Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study.

Eur Respir J · 2022 · PMC7612881 · PMID 34711538

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

However, we found marginally significant associations between higher baseline IL-6 concentrations and unfavorable tuberculosis treatment outcomes when restricted to HIV coinfected participants ( Table-3 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.